ATE420624T1 - Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen - Google Patents

Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen

Info

Publication number
ATE420624T1
ATE420624T1 AT03809756T AT03809756T ATE420624T1 AT E420624 T1 ATE420624 T1 AT E420624T1 AT 03809756 T AT03809756 T AT 03809756T AT 03809756 T AT03809756 T AT 03809756T AT E420624 T1 ATE420624 T1 AT E420624T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical compositions
eye diseases
nanoparticles
ophthalmic
Prior art date
Application number
AT03809756T
Other languages
English (en)
Inventor
Maria Gasco
Gian Zara
Marco Saettone
Original Assignee
Gasco Maria Rosa
Zara Gian Paolo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gasco Maria Rosa, Zara Gian Paolo filed Critical Gasco Maria Rosa
Application granted granted Critical
Publication of ATE420624T1 publication Critical patent/ATE420624T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03809756T 2002-10-31 2003-10-31 Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen ATE420624T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002323A ITMI20022323A1 (it) 2002-10-31 2002-10-31 Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.

Publications (1)

Publication Number Publication Date
ATE420624T1 true ATE420624T1 (de) 2009-01-15

Family

ID=32211395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03809756T ATE420624T1 (de) 2002-10-31 2003-10-31 Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen

Country Status (9)

Country Link
US (1) US20060024374A1 (de)
EP (1) EP1567125B1 (de)
CN (1) CN100594888C (de)
AT (1) ATE420624T1 (de)
AU (1) AU2003301747A1 (de)
CA (1) CA2504199C (de)
DE (1) DE60325887D1 (de)
IT (1) ITMI20022323A1 (de)
WO (1) WO2004039351A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7883031B2 (en) * 2003-05-20 2011-02-08 James F. Collins, Jr. Ophthalmic drug delivery system
US8012136B2 (en) * 2003-05-20 2011-09-06 Optimyst Systems, Inc. Ophthalmic fluid delivery device and method of operation
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
ITMI20041151A1 (it) * 2004-06-09 2004-09-09 Maria Rosa Gasco Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
EP1674085A1 (de) * 2004-12-22 2006-06-28 Universite Libre De Bruxelles Feste Lipidteilchen als pharmazeutische annehmbare Füllstoffe oder Träger zur Inhalation
US9192644B2 (en) * 2006-03-06 2015-11-24 The Regents Of The University Of California Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-related disorders
WO2009013563A2 (en) * 2006-11-13 2009-01-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases or disorders of the eye
JP2010519203A (ja) * 2007-02-16 2010-06-03 メルク・シャープ・エンド・ドーム・コーポレイション 生物活性分子の活性を強化するための組成物及び方法
US20090061009A1 (en) * 2007-08-29 2009-03-05 Joseph Schwarz Composition and Method of Treatment of Bacterial Infections
MX2010007076A (es) * 2007-12-24 2010-09-30 Sun Pharma Advanced Res Co Ltd Nanodispersion.
US20090212133A1 (en) * 2008-01-25 2009-08-27 Collins Jr James F Ophthalmic fluid delivery device and method of operation
ITMI20090284A1 (it) * 2009-02-26 2010-08-27 Consiglio Nazionale Ricerche Uso di inibitori della serina palmitoiltrasferasi per la prevenzione e il rallentamento delle degenerazioni retiniche ereditarie e relative composizioni
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
KR20120050414A (ko) 2009-06-19 2012-05-18 썬 파마 어드밴스트 리서치 컴패니 리미티드 약물의 나노분산액 및 그의 제조 방법
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
KR101545413B1 (ko) 2010-07-15 2015-08-18 아이노비아 인코포레이티드 점적 발생 디바이스
JP2013531548A (ja) 2010-07-15 2013-08-08 コリンシアン オフサルミック，インコーポレイティド 遠隔治療及び遠隔モニタリングを実施する方法及びシステム
US9087145B2 (en) 2010-07-15 2015-07-21 Eyenovia, Inc. Ophthalmic drug delivery
RU2460517C1 (ru) * 2011-07-14 2012-09-10 Федеральное государственное учреждение "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Фармацевтическая композиция для комплексного лечения заболеваний глазной поверхности у больных с первичной открытоугольной глаукомой
US20130172830A1 (en) 2011-12-12 2013-07-04 Corinthian Ophthalmic, Inc. Ejector mechanism, ejector device, and methods of use
JP6251744B2 (ja) 2012-09-07 2017-12-20 ブラッコ・イメージング・ソシエタ・ペル・アチオニＢｒａｃｃｏ Ｉｍａｇｉｎｇ Ｓ．Ｐ．Ａ． ＭＲＩ用の両親媒性錯体を含む常磁性固体脂質ナノ粒子（ｐＳＬＮ）
US9511341B2 (en) 2013-08-30 2016-12-06 Sunny Pharmtech Inc. Method for preparing acetazolamide sodium powder
CA2950741C (en) * 2014-05-30 2023-03-28 Oms Investments, Inc. Nano-sized water-based dispersion compositions and methods of making thereof
EP3203989B1 (de) * 2014-10-09 2019-08-21 Distretto Tecnologico Sicilia Micro e Nano Sistemi S.C.A.R.L. Nanostrukturierte formulierungen zur verabreichung von silibinin und anderen wirkstoffen zur behandlung von augenerkrankungen
KR102643190B1 (ko) 2017-06-10 2024-03-04 아이노비아 인코포레이티드 유체를 취급하기 위한, 그리고 눈에 유체를 전달하기 위한 디바이스들
AU2020353222B2 (en) 2019-09-23 2026-03-19 Ecole Polytechnique Federale De Lausanne (Epfl) Treatment and prevention of aging related-disease and/or aging by the inhibition of sphingolipids
CN115038414A (zh) 2019-12-11 2022-09-09 艾诺维亚股份有限公司 用于向眼睛输送流体的系统和装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904649A (en) * 1986-05-23 1990-02-27 New England Medical Center Hospitals, Inc. Method and solution for treating glaucoma
FR2657018A1 (fr) * 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
IT1292142B1 (it) * 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
IT1298575B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
US20030072794A1 (en) * 2000-06-09 2003-04-17 Teni Boulikas Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
US6720008B2 (en) * 2002-01-22 2004-04-13 Pr Pharmaceuticals, Inc. Composition and method for the encapsulation of water-soluble molecules into nanoparticles
US7067479B2 (en) * 2002-09-30 2006-06-27 Bausch & Lomb Inc. Compositions with enhanced antimicrobial efficacy against E. coli

Also Published As

Publication number Publication date
CA2504199C (en) 2011-10-18
CN100594888C (zh) 2010-03-24
EP1567125B1 (de) 2009-01-14
AU2003301747A8 (en) 2004-05-25
CN1756529A (zh) 2006-04-05
EP1567125A2 (de) 2005-08-31
CA2504199A1 (en) 2004-05-13
US20060024374A1 (en) 2006-02-02
AU2003301747A1 (en) 2004-05-25
ITMI20022323A1 (it) 2004-05-01
WO2004039351A2 (en) 2004-05-13
DE60325887D1 (de) 2009-03-05
WO2004039351A3 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
DE60325887D1 (de) Pharmazeutische zusammensetzungen zurbehandlung von augenerkrankungen
DK1385452T3 (da) Anordning til tilförsel af et ophthalmisk medikament
DE60334692D1 (de) Ophthalmologische zubereitung enthaltend roflumilast in der behandlung von krankheiten der augen
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
CA2508303A1 (en) Drug delivery system using subconjunctival depot
AR041725A1 (es) Prevencion, tratamiento de la enfermedad sinucleinopatica y composicion farmacologica
ATE378058T1 (de) Cannabis extrakten pharmazeutische zusammensetzung
CA2440764A1 (en) Combination of brimonidine and timolol for topical ophthalmic use
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
BR0206568A (pt) Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
ATE444061T1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin- plasmaspiegeln
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
JP2015071553A (ja) 異物感緩和点眼剤
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
BR0209063A (pt) Medicamentos e kits de uso medicinal
AR036877A1 (es) Formulacion farmaceutica
AU2003290015A1 (en) Mastitis treatment
SE9301877D0 (sv) In situ gel for therapeutic use
SE0001916D0 (sv) Novel formulation
NO20013605D0 (no) Preparat for vorter
CA2474703A1 (en) Therapeutic agent of glaucoma comprising bunazosin and prostaglandins
JPH0977656A (ja) 点眼用エアゾル組成物
MA28036A1 (fr) Utilisation d'oxcarbazepine dans le traitement de la douleur liee a la neuropathie diabetique et dans l'amelioration du sommeil
BR122014030158B8 (pt) formulação farmacêutica
RU2002109353A (ru) Способ лимфотропной терапии больных открытоугольной глаукомой с нормализованным внутриглазным давлением

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties